The pharmaceutical field is seeing a significant shift in blood sugar care with the introduction of GLP-1 transdermal devices. These revolutionary delivery systems offer a possibly convenient choice to needle injections for individuals dealing with type 2 diabetes. By bypassing the requirement fo